Crossmark

Intraperitoneal chemotherapy is now back for ovarian cancer

Published Online: 2025-01-29

Published Print: 2025-03

Authors

Fujiwara, Keiichi https://orcid.org/0000-0002-7388-0243
Nagao, Shoji

Tan, David

Hasegawa, Kosei
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (JP22lk0201110)

National University Cancer Institute Singapore Cancer Fund and the National Medical Research Council Singapore
License Information

Text and Data Mining valid from 2025-01-29

Version of Record valid from 2025-01-29
More Information

Article History

Received: 2 November 2024

Accepted: 6 January 2025

First Online: 29 January 2025

Declarations

:

: No author has any conflict of interest.

Document is current